ArticleCancer microenvironment : official journal of the International Cancer Microenvironment Society2015

Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan.

M Vogelhuber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.